A61K 9 - Medicinal preparations characterised by special physical form

Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
11/2011
11/03/2011	WO2011135431A1 Method for introducing at least one compound within erythrocytes for therapeutical and/or diagnostic use
11/03/2011	WO2011135430A1 Controlled release pharmaceutical compositions of brivaracetam
11/03/2011	WO2011135429A1 Apparatus and kit for encapsulating at least one compound for therapeutic and/or diagnostic use in erythrocytes
11/03/2011	WO2011135426A1 Solid oral dosage forms comprising tadalafil
11/03/2011	WO2011135314A2 Pharmaceutical powder compositions
11/03/2011	WO2011135150A1 Hydrogels prepared from natural anionic polymers
11/03/2011	WO2011135106A1 Highly dispersible granulate for the preparation of formulations of high dosage active substances and procedure for the obtainment thereof
11/03/2011	WO2011135055A1 Indigestible polymer: starch acetate -based film coatings for colon targeting
11/03/2011	WO2011134979A2 Stable mia/cd-rap formulation
11/03/2011	WO2011134962A2 Orally disintegrating tablet containing acarbose
11/03/2011	WO2011134944A2 Low-oil pharmaceutical emulsion compositions comprising progestogen
11/03/2011	WO2011134937A2 Pharmaceutical emulsion compositions comprising progestogen
11/03/2011	WO2011134887A1 Novel coating system
11/03/2011	WO2011134846A1 Oral dosage forms
11/03/2011	WO2011134722A1 Methods and compositions for reversibly reducing the aural sensitivity of humans and animals
11/03/2011	WO2011134679A2 Selected plant extracts for the treatment of inflammatory diseases
11/03/2011	WO2011134675A1 Carrier and targeting system comprising a siosomal composition for intracellular delivery and targeting of active substance
11/03/2011	WO2011134369A1 Pharmaceutical composition for improving solubility of prasugrel and its preparation method
11/03/2011	WO2011134191A1 Compound pharmaceutical formulation
11/03/2011	WO2011134119A1 7,2''-dehydrated puerarin, its salts derivatives, and its preparative methods and uses
11/03/2011	WO2011134026A1 Cosmetic methods and compositions
11/03/2011	WO2011107653A3 Use of levodopa, carbidopa and entacapone for treating parkinson's disease
11/03/2011	WO2011087779A3 Cell tissue gel containing collagen and hyaluronan
11/03/2011	WO2011085256A3 Treatment of obstructive sleep apnea syndrome with a combination of a carbonic anhydrase inhibitor and an additional active agent
11/03/2011	WO2011084925A3 Biomaterials made from human hair
11/03/2011	WO2011080570A3 Extended release pharmaceutical composition comprising linezolid and process for preparing the same
11/03/2011	WO2011074851A3 Pharmaceutical preparation
11/03/2011	WO2011074791A3 Pharmaceutical composition containing telmisartan and hydrochlorothiazide
11/03/2011	WO2011074782A3 Liposome composition, preparation method thereof, and usage of the composition as pneumonia vaccine
11/03/2011	WO2011065754A3 Device for vaporisation and inhalation, a composition for vaporisation and inhalation used therewith, and a method for vaporising the composition for vaporisation and inhalation
11/03/2011	WO2011061516A3 Topical foam composition
11/03/2011	WO2011056775A3 Microcrystalline cellulose and calcium phosphate compositions useful as pharmaceutical excipients
11/03/2011	WO2011049540A3 The pharmaceutical composition in dry powder form for inhalation
11/03/2011	WO2011049538A3 Pharmaceutical composition in dry powder form
11/03/2011	WO2011049419A3 Face support having a drug carrier
11/03/2011	WO2011034394A3 Oxaliplatin nanoparticles and method for preparing same
11/03/2011	WO2011027990A3 Extracellular vesicles derived from gram-positive bacteria, and use thereof
11/03/2011	WO2011012637A4 Subcutaneous anti-her2 antibody formulation
11/03/2011	WO2011003406A3 Mixture of amphipathic molecules and method for modifying cell membranes by means of fusion
11/03/2011	WO2010143970A3 Acoustically sensitive drug delivery particles comprising non-lamellar forming phosphatidylcholine
11/03/2011	WO2010133975A3 Reducible polyamino disulfides as transfectants
11/03/2011	WO2010118238A3 Controlled release devices and methods for delivery of nucleic acids
11/03/2011	WO2009085310A8 Extended-release pharmaceutical compositions containing zolpidem
11/03/2011	US20110270259 Paste-powder dual polymer-based bone cement and injection apparatus for same
11/03/2011	US20110270165 Compositions for treatment and use of a palatal patch
11/03/2011	US20110270156 High shear application in medical therapy
11/03/2011	US20110270151 Image-guided energy deposition for targeted drug delivery
11/03/2011	US20110270045 Microprocessor controlled ambulatory medical apparatus with hand held communication device
11/03/2011	US20110269947 Apo-2 ligand/trail formulations
11/03/2011	US20110269723 Spill resistant formulations containing clays
11/03/2011	US20110269710 Pharmaceutical composition of complex carbohydrates and essential oils and methods of using the same
11/03/2011	US20110268970 Mesoporous nanoparticles
11/03/2011	US20110268819 Antinfective free intramammary veterinary composition
11/03/2011	US20110268810 Polymeric materials loaded with mutagenic and recombinagenic nucleic acids
11/03/2011	US20110268809 Nicotine-Containing Pharmaceutical Compositions
11/03/2011	US20110268808 Dual-release pharmaceutical suspension
11/03/2011	US20110268807 Biodegradable Microspheres and Methods of Use Thereof
11/03/2011	US20110268806 Antisolvent solidification process
11/03/2011	US20110268805 Adjuvant incorporation in immunonanotherapeutics
11/03/2011	US20110268804 Targeting of antigen presenting cells with immunonanotherapeutics
11/03/2011	US20110268803 Lung targeting dual drug delivery system
11/03/2011	US20110268802 Delivery particle
11/03/2011	US20110268801 Novel compounds and compositions and methods of use
11/03/2011	US20110268800 Unsaturated fatty acids as thrombin inhibitors
11/03/2011	US20110268799 Oral controlled release dosage form
11/03/2011	US20110268798 Orally disntegrating tablets for the treatment of pain
11/03/2011	US20110268797 Multicoated aliskiren formulations
11/03/2011	US20110268796 Pharmaceutical formulations useful in the treatment of insomnia
11/03/2011	US20110268795 Compositions and methods for inducing satiety and treating non-insulin dependent diabetes mellitus, prediabetic symptoms, insulin resistance and related disease states and conditions
11/03/2011	US20110268794 Methods and materials for delivering bile acids
11/03/2011	US20110268793 Kits and methods for nutrition supplementation
11/03/2011	US20110268792 Surface active proteins as excipients in solid pharmaceutical formulations
11/03/2011	US20110268791 Porous nanoparticle supported lipid bilayer nanostructures
11/03/2011	US20110268790 Snake Factor V and Methods of Use Thereof as a Procoagulant
11/03/2011	US20110268789 Use of pituitary adenylate cyclase-activating polypeptide (pacap) and pacap analogs as adjunctive treatments with anticancer agents
11/03/2011	US20110268788 Immunotherapeutic agent suitable for the primary prophylaxis of tuberculosis
11/03/2011	US20110268787 Ocular compositions containing dioleoylphosphatidylglycerol and uses thereof
11/03/2011	US20110268786 Patch production technology
11/03/2011	US20110268785 Propynylaminoindan Transdermal Compositions
11/03/2011	US20110268784 Clay-based hemostatic agents and devices for the delivery thereof
11/03/2011	US20110268783 Partially microcellular, selectively hydrophilic composite construct for ocular drug delivery
11/03/2011	US20110268779 Gum compositions
11/03/2011	US20110268776 Programmed-release, nanostructured biological construct for stimulating cellular engraftment for tissue regeneration
11/03/2011	US20110268775 Nanoparticle pharmaceutical formulations
11/03/2011	US20110268774 preparation of stem cells with reprogrammed cell signalling, a method of producing the preparation and a method of use thereof
11/03/2011	US20110268773 Inclusion bodies, bacterial cells and compositions containing them and uses thereof
11/03/2011	US20110268772 Pharmaceutical composition containing an anionic drug and a production method thereof
11/03/2011	US20110268771 Chewable gelled emulsions
11/03/2011	US20110268770 Chewable gelled emulsions
11/03/2011	US20110268769 Drug delivery vehicle for cancer therapy, process for producing the same, and pharmaceutical preparation using the same
11/03/2011	US20110268768 Compositions and Methods for Treating Atherosclerosis
11/03/2011	US20110268669 Composition and method for treating eustachian tube dysfunction
11/03/2011	US20110268668 Process for nebulizing aqueous compositions containing highly concentrated insulin
11/03/2011	US20110268666 Novel gastroretentive delivery system
11/03/2011	US20110268665 Oil-based foamable carriers and formulations
11/03/2011	US20110268664 Composition for addition to drinking water
11/03/2011	US20110268655 Anti-alpha v immunoliposome compositions, methods and uses
11/03/2011	US20110268653 Compositions and Methods Related to Acid Stable Lipid Nanospheres
11/03/2011	US20110266517 Peptide nanostructures encapsulating a foreign material and method of manufacturing same
11/03/2011	US20110265786 Inhalable Formulations For Treating Pulmonary Hypertension And Methods Of Using Same

1 ... 622 623 624 625 626 627 628 629 630 631 632 633 634 635 636 637 638 639 640 641 642 ... 2991